CONCLUSIONS: Reductions in NFL and GCC thickness can predict the development of glaucomatous VF loss in glaucoma suspects and preperimetric glaucoma patients. (Am J Ophthalmol 2016; 163:29-37 . Ó 2016 by Elsevier Inc. All rights reserved.)
A FUNDAMENTAL CHALLENGE WITH GLAUCOMA suspects is to estimate glaucoma progression risks and to intervene before significant damage to vision occurs. The appearance of risk factors on initial presentation can vary greatly. For instance, an individual with ocular hypertension may have a normal-appearing disc while another patient might have an abnormally high cup-to-disc ratio (CDR) but a low to normal intraocular pressure (IOP). Several studies have tried to identify and combine anatomic, visual field (VF), and epidemiologic variables to create a risk calculator. Investigators in the Ocular Hypertension Treatment Study (OHTS) 1 and in OHTS validation studies 2,3 developed a formula that tries to predict the onset of primary open-angle glaucoma (POAG) using a number of standard glaucoma variables: IOP, central corneal thickness (CCT), CDR, and VF indices. Although this formula summarizes standard clinical observations, the accuracy of predicting glaucoma conversion (ie, development of definitive glaucomatous damage in a suspect) was only fair, with the area under the receiver operating characteristic curve (AUC) of 0.68, according to an independent study. 2 The accuracy of the OHTS calculator is limited by the variability of component variables, especially IOP, VF, and the CDR derived from subjective clinician grading. Song and associates found that within the same individual, the estimated risk can vary almost 10-fold. 4 Using digital imaging-derived variables to predict glaucoma conversion may provide greater accuracy owing to their objective and automated nature. Imaging also requires less sustained attentiveness from the test subject, a consideration that is especially relevant in the older age group affected by glaucoma. 1, 5 In this study, we investigate the use of Fourier-domain optical coherence tomography (FD OCT) anatomic measurements to predict the development of glaucomatous VF damage.
METHODS

PARTICIPANTS:
The data used for the study were taken from participants enrolled in the Advanced Imaging for Glaucoma (AIG) Study, a multisite bioengineering partnership and longitudinal prospective clinical study sponsored by the National Eye Institute (ClinicalTrials.gov identifier: NCT01314326). The study design and baseline participant characteristics have been published in a separate paper, 6 and the Manual of Procedures is available online (www.AIGStudy.net). Clinical data for the AIG Study were collected from 3 clinical centers, including the Doheny Eye Institute then at the University of Southern California (Now at University of California, Los Angeles), the University of Pittsburgh Medical Center, and the Bascom Palmer Eye Institute at the University of Miami. The study procedures adhered to the Declaration of Helsinki, which guides studies involving human subjects. Written consent was obtained from all of the participants and proper institutional review board approvals were obtained from all of the participating institutions.
One of the specific aims of the study was to predict conversion in glaucoma suspect and preperimetric glaucoma (GSPPG) eyes. The eyes categorized as glaucoma suspect (GS) do not have abnormal VF pattern standard deviation (PSD) or glaucoma hemifield test (GHT), and either the eye had ocular hypertension (IOP > _22 mm Hg) or the fellow eye had perimetric glaucoma. Preperimetric glaucoma (PPG) eyes do not have abnormal VF PSD or GHT, but have a glaucomatous appearance of the disc or nerve fiber layer (NFL) on dilated ophthalmoscopy, defined as vertical cup-to-disc asymmetry greater than 0.2, notch or thinning of the neuroretinal rim, optic disc hemorrhage, or NFL defect. GS and PPG participants were seen every 6 months and received a comprehensive eye examination, VF tests, and imaging using FD OCT that was included in the AIG Study as a standard imaging procedure in 2006. Cataract patients were not excluded from the AIG Study. Details about inclusion and exclusion criteria are available online (www.AIGStudy.net). The VF tests were done on standard automated perimetry and repeated at least twice to get a reliable reading.
OPTICAL COHERENCE TOMOGRAPHY IMAGING: Three anatomic regions-the optic disc, peripapillary NFL, and macular ganglion cell complex (GCC)-were imaged and measured by FD OCT (RTVue; Optovue, Inc, Fremont, California, USA). During each visit, participants had 3 GCC and optic nerve head (ONH) scans. Only ONH scans with a signal strength index (SSI) above 37 and GCC scans above 42 were selected for analysis. Measurements in qualified scans in the same visit were averaged.
The macular GCC scan covered a 7 3 7-mm 2 area in the macula. Scans were centered 0.75 mm temporal to the fovea to improve the coverage of the temporal macula.
The macular GCC thickness was defined as the combination of NFL, GCL, and inner plexiform layer. 7 The automated Optovue software derived a 6-mm-diameter GCC thickness map centered 0.75 mm temporal to the fovea.
The ONH scans consisted of concentric (1.3-4.9 mm diameter) scans and radial scans (3.4 mm length) centered on the optic disc and automatically registered with the 3-dimensional disc scan to provide the disc margin information. The NFL thickness profile at D ¼ 3.4 mm was resampled on the NFL map recentered according to the detected optic disc center. The radial scans were segmented to calculate the CDRs and optic disc rim area.
The RTVue software (version 6.12) was used to provide the following OCT image-derived measurements: (1) the overall, superior, and inferior hemisphere averages of the GCC thickness map; (2) the overall, superior, and inferior quadrant averages of the NFL thickness profiles; (3) CDRs and rim area; and (4) the pattern analysis of the GCC thickness map. In pattern analysis, the global loss volume (GLV) was used to measure a pattern of diffuse loss, whereas the focal loss volume (FLV) was used to measure more focal losses. 7 Pattern analysis was also applied to the NFL using custom software by coauthor Ou Tan. The NFL pattern analysis is analogous to the RTVue GCC pattern analysis, but based on the NFL profile instead of the GCC map. 8 
GLAUCOMA CONVERSION
EVENT: The primary outcome event for participants in the GSPPG group was conversion to a confirmed abnormal VF, where PSD became abnormal (P < 5%) or GHT fell outside of normal limits on 3 consecutive tests. This required a minimum of 4 total visits including the baseline visit, equivalent to a minimum of 1.5 years in follow-up time. Confirmation of VF conversion also required the clinical investigator to review the most recent eye examinations and determine that the VF change was likely due to glaucoma rather than confounding conditions such as cataract, macular disease, or other nonglaucomatous conditions. The conversion time was defined at the time of final confirmation.
STATISTICAL ANALYSIS: All statistical analyses were performed by SAS 9.3 (SAS Institute, Cary, North Carolina, USA). The primary analysis used Cox regression, 9 which is suitable for time-to-event data. The participants had to have at least 3 follow-up visits to be eligible for inclusion in the analysis. For each of the covariates in the analysis, we provided a hazard ratio (HR) estimate and the corresponding P value. We also provided the AUC for the covariate to compare its relative predictive power in glaucomatous conversion.
For each of the FD OCT measurements, such as GCC overall thickness, borderline and abnormal categories were defined against normal values. Such categories are shown in yellow (borderline), red (abnormal), and green (normal) on the printout from the Optovue device. These categories were determined by cutoff values based on the proprietary database maintained by Optovue, Inc. Typically ''borderline'' represents values between the first and fifth percentile of the normal population, and ''abnormal'' represents values below the 1 percentile cutoff.
For categorical covariates, Kaplan-Meier survival curves were produced, and log-rank tests were used to compare risks among categories. We also provided HRs for IOP analysis, which, unlike other covariates, were recorded at the baseline visit. Four of the 5 IOP covariates were summaries from the baseline to the time of the conversion event or censoring (described below), including average, peak, range, and variation. It should be noted that the IOPs were measured from a mix of treated and untreated eyes, according to the decision of the patient and treating physician, as the treatment regimen is not mandated or randomized in the AIG Study.
Because many participants had both eyes enrolled in this study, we used a robust sandwich covariance estimation method in the Cox regression to adjust for this potential correlation. 10 For other analyses, the generalized estimating equations method 11 was used when applicable to adjust for intereye correlation.
All of the potential covariates were evaluated to build an optimal multivariate Cox regression model through a combination of manual elimination and automatic stepwise selection processes. When the optimal combination of the covariates was determined, the linear form was transformed through a logistic function. The resulting value, which ranged from 0 to 1, was defined as the glaucoma composite conversion index (GCCI). Values closer to 1 implied a higher risk of conversion. To avoid overestimate prediction accuracy of the GCCI, leave-one-out cross-validation (LOOCV) was used to calculate the AUC for GCCI.
All statistical analyses were performed with the SAS 9.3 software package (Cary, North Carolina, USA). The level of significance was set at P < .05.
RESULTS
AMONG THE GSPPG GROUP CONSISTING OF 664 EYES FROM
394 participants, 513 eyes of 305 participants were included in the analysis while 151 eyes from 89 participants were excluded owing to fewer than 3 follow-up visits. In 21 participants, data following glaucoma surgeries were censored, while data preceding the surgeries were used. These surgeries included trabeculectomy, laser trabeculoplasty, glaucoma drainage device implantation, or laser iridotomy. After 41 6 23 months of follow-up, 55 eyes from 46 participants experienced VF conversion.
The Venn diagram ( Figure 1 ) details the distribution of PPG and perimetric glaucoma (PG) participants based on enrollment criteria. Notably, the cohort had a majority of PPG (n ¼ 359, 70%). Most GS participants (n ¼ 154) had ocular hypertension, with a small fraction having PG in the fellow eye. Table 1 summarizes the demographic characteristics of the cohort. Glaucomatous converters were significantly more likely to be female and to be treated with topical glaucoma medication. Older age was a risk factor of borderline significance. Race, systemic hypertension, diabetes, and family history of glaucoma were not significantly associated with conversion. Univariate Cox analysis also showed that these covariates were not significant risk factors. Table 2 describes ocular characteristics. Univariate Cox regression analysis showed that female sex (HR ¼ 2.0, P ¼ .04) was a significant risk factor. CCT and axial length were similar in converters and nonconverters. There were also no differences between IOP averages and peaks of either group, but participants who converted had a wider IOP range and variation. Visual field stage, mean deviation (MD), PSD, and visual field index (VFI) were worse in participants who converted. Except for horizontal CDR, all FD OCT variables under study were significantly worse among converters.
Among the continuous baseline clinical variables (Table 3) , age and VFI were significant risk factors. Baseline IOP and CCT were not significant risk factors. Judging by the AUC, the VFI was the strongest non-OCT baseline predictive factor.
All FD OCT variables listed in Table 3 were significant predictive factors except for horizontal CDR. Among disc FIGURE 1. Glaucoma suspect and preperimetric glaucoma group composition. The percentage in parentheses is the percentage of conversion, and the number in the parentheses is the length of follow-up in months. Those with ophthalmoscopic optic nerve head/nerve fiber layer (ONH/NFL) defect (entire top circle) represent the preperimetric glaucoma (PPG) subgroup, while the remainder represent the glaucoma suspect (GS) subgroup. PG, perimetric glaucoma.
variables, vertical CDR had the highest predictive value by AUC, while among NFL variables, overall average, GLV, and FLV were the strongest predictors. All GCC variables were strong predictors except the superior hemispheric average. The strongest single predictive variable was the GCC-FLV.
Clinicians often rely on the classification of OCT variables such as ''normal,'' ''borderline,'' and ''abnormal'' using the criteria based on the manufacturer-supplied normative reference. The FD OCT manufacturer (Optovue) provides normative classification for most GCC and NFL variables, but not disc variables. The Supplemental Table (Supplemental Material available at AJO.com) analyzes the conversion risk associated with the normative classifications of the key GCC and NFL variables. Among all GSPPG eyes analyzed, 42.6% had at least 1 abnormal or borderline FD OCT variable at baseline. Of those eyes, 16.7% experienced VF conversion, at 23 6 17 (mean 6 SD) months of follow-up. In comparison, only 3.1% of those with normal FD OCT measurements at baseline had VF conversion.
When we analyzed all eyes that converted, 70.9% of those had an abnormal or borderline FD OCT variable at baseline visit, and 81.8% had an abnormal or borderline FD OCT variable at the time of conversion.
Consistent with the analysis of the continuous variables above, GCC-FLV was again the most predictive of the FD OCT variables. A borderline GCC-FLV classification raised the conversion risk 3.8-fold, while an abnormal classification raised the risk 5-fold in the univariate Cox regression model. Based on Kaplan-Meier survival curves, eyes with borderline or abnormal reading in GCC-FLV at baseline had almost 4 times as much risk after 6 years compared to those with normal GCC-FLV at baseline ( Figure 2) . A borderline or abnormal GCC-FLV predicted conversion during the AIG study period with a sensitivity of 40% and a specificity of 88.4%, with an overall accuracy of 83.2%. The positive predictive value (PPV) was 29.3% and the negative predictive value (NPV) was 92.5%. Of all eyes that converted, 40.0% of those had an abnormal or borderline GCC-FLV at the baseline visit, and 50.9% had an abnormal or borderline GCC-FLV at the time of conversion. In contrast, of eyes that did not convert, only 11.6% had an abnormal or borderline GCC-FLV reading at baseline and 14.7% had an abnormal or borderline GCC-FLV at the last follow-up.
Since clinical glaucoma management is based on using all available diagnostic information, we combined the available demographic, clinical, and FD OCT continuous variables together to construct the GCCI. First, baseline covariates with univariate Cox regression HRs at a significance level of P < .1 were included: age, sex, ophthalmoscopic rim/NFL defect, MD, PSD, VFI, and all of the FD OCT measures (Table 3 ) except for horizontal CDR. Next, these candidate covariates were run through an automatic stepwise selection/elimination process, where the P value for elimination was set at .05. The final components that made up the GCCI included VF PSD, age, inferior NFL, and GCC-FLV. The components were then added together with the optimized weight coefficients (Table 4) to produce the composite index, with a value ranging from 0 to 1. The GCCI AUC of 0.783 performed marginally better (P ¼ .04) than the best-performing single variable, including GCC-FLV, which had an AUC of 0.753 (P < .001 for test against AUC ¼ 0.5, Table 3 ). We applied exact same model selection procedure on all available candidate variables except for the OCT variables; the resulting model included baseline age, PSD, and MD, with AUC ¼ 0.708. Finally we applied the procedure on OCT variables only; the resulting model under this selection included only GCC-FLV and inferior NFL, with AUC ¼ 0.760. Both models from the sub-selection provided less AUC than the model from the full selection. VOL. 163 33 COMBINE CLINICAL VARIABLES TO PREDICT GLAUCOMA CONVERSION Using the Cox regression model, the probability of VF conversion could be predicted as a function of time and GCCI (Figure 3) . Eyes with GCCI below 0.6 had low conversion risk (<5%), while those with a GCCI above 0.8 had high conversion risk (>80%) after 6 years of followup. We also looked at the actual conversion rate among the GSPPG eyes analyzed and found that GCCI was highly predictive ( Table 5 ). The eye with the lower half of GCCI values (<0.72) had less than 4.4% conversion rate, while those with the highest quartile of GCCI values (>0.84) had a highly elevated conversion risk of 29.7% during the AIG study period. Using a value of 0.84 as the cutoff for the entire GSPPG group, GCCI predicted VF conversion with a sensitivity of 60% and a specificity of 83%, with an overall accuracy of 80.5%. The PPV was 29.7% and the NPV was 94.5%. Using the same cutoff, for the PPG subgroup, the GCCI had sensitivity of 58% and specificity of 80.7%, with an overall accuracy of 78%; for the GS subgroup, the GCCI had sensitivity of 66.7% and specificity of 88%, with an overall accuracy of 86.4%.
DISCUSSION
THE MANAGEMENT OF GLAUCOMA IN THE EARLY STAGES
presents a dilemma. On the one hand, it is desirable to start treatment early to prevent irreversible damage to the optic nerve and visual disability. On the other hand, all treatment options have significant cost and side effects, which are best avoided in patients who do not have glaucoma or have such a slowly progressive disease that debilitating VF loss is highly unlikely within their lifetime. To offer greater ease and consistency in the management of glaucoma suspect participants, risk calculators have been developed that include anatomic, epidemiologic, and functional data. The most established risk calculator is based on data from the OHTS and the European Glaucoma Prevention Study. 3 It includes the IOP, CCT, age, CDR, and VF PSD. The OHTS-derived model has been tested in an independent study population. 2 The AUC ranged from 0.68 to 0.73, indicating a moderate predictive value. One of the challenges of using the OHTS risk model is that there is considerable variability in the measurement of its component variables. IOP, vertical CDR, VF PSD, and even CCT 4 can all differ significantly in the same individual between visits and when assessed by different examiners and instrumentation. As a result, the estimated 5-year risk of glaucoma conversion can vary up to 10 times between follow-up visits. 4 Therefore, it is desirable to assess conversion risk using FD OCT, which offers relatively reproducible anatomic measurements. Various studies put the NFL reproducibility in terms of coefficient variation at 1.5%-4% 12 and GCC at 0.4%-2.8%. 13, 14 In the normal participants of the AIG Study, the reproducibility, measured as the coefficient of variation, for overall average thickness was 2.1% for NFL and 1.5% for GCC (unpublished data).
Our study did show that many baseline OCT anatomic measurements had a significant predictive value (P < .001 for testing against AUC ¼ 0.5). While there were participants with an abnormal OCT who did not convert during follow-up, GSPPG eyes with a borderline or abnormal FD OCT finding in the listed NFL or GCC variables had 5 times the chance of conversion of those with all normal FD OCT findings. In general, the macular GCC variables were the most reliable predictors, with the GCC-FLV being the most reliable of all. The AUC of the GCC-FLV was 0.753, which by itself was higher than that of the OHTS risk calculator at 0.73.
2 By adding NFL information, age, and VF PSD in a Cox model, the GCCI had a marginally higher AUC of 0.783. We must caution, however, that no direct conclusion can be based on comparisons of the GCC-FLV and GCCI in the AIG Study with the results of the OHTS and other studies because of differences in the study design and participant population. Further studies that use both risk models and calculators are needed for a fair comparison of predictive accuracy. Another caveat is that, although the LOOCV method was used, the GCCI was not developed and tested on entirely differently populations. It is possible that the performance may see variation on independent test groups.
A notable negative finding in the AIG Study was that the CCT, baseline IOP, and mean follow-up IOP were not significant risk factors. This is probably because treatment was not randomized in our study and the clinicians made treatment decisions based on these known risk factors. The intensity of treatment might therefore have been influenced by insights gained in the OHTS. Therefore, our study design does not allow us to make any conclusion on the predictive value of CCT or IOP. Thus, our results do not contradict the OHTS and other studies that confirmed the predictive values of CCT and IOP. A recent study highlighted the importance of lowering IOP even at the preperimetric stage by showing with linear regression analysis a significant negative association between the percent reduction in intraocular pressure and rate of change in standard automated perimetry mean deviation. 15 We did find that IOP peak, range, and variation were predictors of conversion, which supports the finding of these same IOP indices as risk factors for VF progression in the Advanced Glaucoma Intervention Study. 16 One reason that we did not mask IOP, VF, and CCT information or randomize glaucoma treatment in the AIG Study was because these risk factors were already well established by OHTS; therefore, denying the use of this information in patient management would have been unethical. It should be noted that the OCT measurements were masked to the clinical investigators/treating physicians and patients during the AIG Study. Therefore we are able to make valid inferences on the predictive value of OCT variable without any direct confounding effect.
The reason that FD OCT anatomic measurements were predictive of subsequent VF conversion is probably because the instrument was detecting early glaucoma damage that was at the cusp of being detectable on a VF test. In most patients, anatomic damage can be detected earlier than the appearance of VF defects. 17, 18 When objective, topographic optic disc measurements were obtained in participants of the OHTS validation study 2 using confocal scanning laser ophthalmoscopy, a larger CDR, cup depth, and volume and smaller rim area and rim volume were found to predict POAG with a PPV of 14%-40% (NPV not given). 19 In comparison, PPV and NPV in our study were 29.7% and 94.5%, using a GCCI cutoff value of 0.84. This cutoff value worked well for both the GS and PPG subgroups. Of the predicted VF conversions, FD OCT findings (abnormal or borderline NFL or GCC) preceded conversion by 23 months on average. This is a significant period of time in which earlier treatment could have had an impact on the course of disease.
Of all predictors in our study, GCC-FLV was the most reliable by far. One possible explanation is that the focal structural loss may be a more reliable indication of early glaucoma damage than diffuse thinning, which is more likely to be a normal anatomic variant. This is consistent with a recent study by Mwanza and associates, in which the authors found that the minimal radial sector of focal macular loss can be a powerful approach to diagnose glaucoma, 20 and with a glaucoma structural diagnostic index from the AIG Study, which also found GCC-FLV useful. 8 Furthermore, the macular GCC is mapped over a wider area than the peripapillary NFL, which may allow for a more accurate detection of focal loss. In the AIG Study, VF conversion was defined by PSD or GHT but not by MD. The PSD and GHT indices are more sensitive to focal VF defects that may correspond better to macular structural loss measured by GCC-FLV. Finally, focal loss that involves the macula may be a common pattern of glaucoma damage and reflective of the increased vulnerability of the inferotemporal disc 21, 22 and inferior macula or superior visual field, 23 respectively.
OCT results were masked to the treating clinicians during the study period; therefore, the structural changes detected by OCT do not affect treatment decisions. Of course, optic disc cupping and rim defects, RNFL bundle defect, and disc hemorrhages that are ophthalmoscopically visible would affect treatment decisions, since this standard clinical information cannot be ethically masked. To the extent that this ophthalmoscopic evidence of glaucoma damage could be partially correlated with OCT evidence of damage, the predictive performance of OCT could be decreased. Therefore the hypothetical AUC values of OCT variables and composite indices could be higher in a hypothetical study where there is no treatment or if the treatments are randomized. This does not detract from the conclusion that OCT provides useful prognostic information.
Our finding that more than 70% of converters had abnormal or borderline GCC or NFL variables at baseline in contrast to nonconverters suggests that the GCC and NFL defects often seen on FD OCT scans may be true glaucomatous damage even in the absence of concurrent VF defects. We propose that OCT measurements, especially GCC-FLV, may be valuable surrogate endpoints in studying the benefit of treatments in preventing glaucomatous progression in the early stages of the disease. Using such OCT endpoints would address the need for better, standardized, and objective glaucoma testing that is less dependent on the examiner's experience and the participant's performance.
In conclusion, FD OCT variables are useful to assess the risk of conversion to PG. Individuals who have abnormal or borderline OCT parameters, especially those affecting the macula, may require closer follow-up and initiation of treatment to avoid vision loss. Combining anatomic and VF variables appears to be synergistic in the assessment of glaucoma conversion risk. A list of members of the Advanced Imaging for Glaucoma Study Group and details regarding their financial disclosures are included as an appendix (Supplemental Material available at AJO.com).
